Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Powder Life is an Oxford-based life sciences company focused on the development of a proprietary platform for the stabilization and delivery of vaccines and biopharmaceuticals in dry powder form. The company's technology aims to solve the global cold-chain challenge by creating shelf-stable formulations that do not require refrigeration, which is critical for distribution in resource-limited settings. Their proprietary particle engineering process is designed to maintain the structural and functional integrity of complex biological molecules during the drying process. Powder Life's approach also facilitates needle-free delivery methods, potentially increasing patient compliance and ease of administration. The firm is led by a team with significant expertise in particle engineering and vaccine development, leveraging legacy knowledge from the dry-powder delivery sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Powder Life.